Single-Cell Omics Market Size, Share, Trends, and Forecast 2024

"The Business Research Company recently released a comprehensive report on the Global Single-Cell Omics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

According to The Business Research Company's, The single-cell omics market size has grown rapidly in recent years. It will grow from $1.81 billion in 2023 to $2.1 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to cellular heterogeneity discovery, emergence of single-cell analysis tools, biomedical research progress, immune system characterization, rise of precision medicine.

The single-cell omics market size is expected to see rapid growth in the next few years. It will grow to $3.84 billion in 2028 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to clinical adoption and diagnostics, integration with multi-omics approaches, application in regenerative medicine, drug development and discovery, cellular therapies and immunotherapies. Major trends in the forecast period include in vivo single-cell studies, single-cell omics in infectious disease research, microfluidics and single-cell sorting, single-cell multi-omics integration, spatial single-cell profiling.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Market Drivers and Trends:

The rising prevalence of cancer is expected to propel the growth of the single-cell omics market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Identifying biomarkers for cancer diagnosis, prognosis prediction and discovering novel therapeutic targets in predetermined clinical cohorts has made substantial use of single-cell omics data. For instance, in 2023, according to the American Cancer Society Inc., a US-based non-profit health group, 1.9 million new cancer cases are expected to be diagnosed in the US in 2021, an increase compared to more than 1.8 million new cancer cases diagnosed in 2020. Therefore, the rising prevalence of cancer is driving the growth of the single-cell omics market.

Product innovation is a key trend gaining popularity in the single-cell omics market. Major companies operating in the single-cell omics market are developing innovative products to sustain their position in the market. For instance, in May 2023, Deepcell, a US-based software provider for single-cell dimensional morphology analysis, launched REM-I Platform, a scalable single-cell imaging, high-dimensional analysis, and cell sorting that provide previously unattainable insights into cell biology. The REM-I Platform will stimulate new ways of discovery in various domains, including cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening, among others, by combining single-cell imaging, sorting, and high-dimensional analysis.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

Single-Cell Omics Market 2024 Key Insights:

• The single-cell omics market size is expected to see rapid growth in the next few years. It will grow to $3.84 billion in 2028 at a compound annual growth rate (CAGR) of 16.2%.
• Rising Cancer Prevalence Propels Growth In The Single-Cell Omics Market
• Product Innovation Marks A Milestone In Single-Cell Omics Market
• North America was the largest region in the single-cell omics market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=12379&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.